Baltimore, MDNCT06170541Now EnrollingIRB Ready

Coronary Heart Disease (CHD) Clinical Trial in Baltimore, MD

Access cutting-edge coronary heart disease (chd) treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Johns Hopkins University

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access coronary heart disease (chd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related coronary heart disease (chd) treatment provided free

Apply for This Baltimore Location

Check if you qualify for this coronary heart disease (chd) clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Coronary Heart Disease (CHD) Study in Baltimore

The utility of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in all-comers (i.e., a generally lower-risk population) remains uncertain but is an important area of study in order to justify wider spread implementation and use of this technology, particularly in light of reports of significantly higher radiation exposure with UHR-CT, as well as longer scan times. The availability of technology to reconstruct conventional resolution (CR) simulation images from the raw CT acquisition data acquired on the UHR-CT scanner offers a unique platform to study this question without subjecting individuals to two different scans. The primary objective of this study is to generate preliminary data in support of the hypothesis that noninvasive UHR-CT is superior to conventional resolution CT for identifying patients with obstructive CHD.

Sponsor: Johns Hopkins University

Who Can Participate

Inclusion Criteria

Patients aged 21-85 years
Clinical history suggestive of CHD who are referred by their primary cardiologist for further evaluation via Computed tomography angiography (CTA) will be asked to participate.
Women of child bearing potential must demonstrate a negative pregnancy test within 24 hours of the study CTA.
Ability to understand and willingness to sign the Informed Consent Form.

Exclusion Criteria

Known allergy to iodinated contrast media.
History of multiple myeloma or previous organ transplantation
Elevated serum creatinine (\> 1.5mg/dl) OR calculated creatinine clearance of \< 60 ml/min (using the Cockcroft-Gault formula
Atrial fibrillation or uncontrolled tachyarrhythmia, or advanced atrioventricular block (second or third degree heart block)
Evidence of severe symptomatic heart failure (NYHA Class III or IV);
Known or suspected moderate or severe aortic stenosis
History of prior percutaneous coronary intervention (PCI) in one or more vessel or history of coronary arterial bypass grafting (CABG)
Suspected acute coronary syndrome
Presence of any other history or condition that the investigator feels would be problematic

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT06170541) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Coronary Heart Disease (CHD) Treatment Options in Baltimore, MD

If you're searching for coronary heart disease (chd) treatment options in Baltimore, MD, this clinical trial (NCT06170541) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced coronary heart disease (chd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all coronary heart disease (chd) clinical trials near you to find additional studies recruiting in your area.

More Heart Disease Trials in Baltimore, MD

See all heart disease clinical trials recruiting in Baltimore — not just this study.

Browse Heart Disease Trials in Baltimore →

Browse More Trials by Condition

Heart Disease TrialsHuntingtons Disease TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD